Effect of metformin on renal function after primary percutaneous coronary intervention in patients without diabetes presenting with st-elevation myocardial infarction: data from the gips-iii trial

HIGHLIGHTS

• who: Cardiovasc Drugs Ther ( et al. from the Department of Critical Care, University of Groningen, University RB Groningen, The Netherlands have published the article: Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial, in the Journal: (JOURNAL)
• what: The study medication was initiated as soon as possible after PCI, with the aim of administering the first dose within 3 h after PCI. The main reason for missing creatinine values at 48 h was early discharge of low . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.